NASDAQ:ENVX • US2935941078
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENOVIX CORP (ENVX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-12 | B of A Securities | Initiate | Neutral |
| 2026-02-26 | TD Cowen | Maintains | Hold -> Hold |
| 2026-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-02-26 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-11-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-06 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-04 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-25 | Benchmark | Maintains | Buy -> Buy |
| 2025-07-24 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-07-10 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-07-08 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-05-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-01 | TD Securities | Maintains | Hold -> Hold |
| 2025-04-29 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-04-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-15 | Benchmark | Maintains | Buy -> Buy |
| 2025-02-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-20 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-10-31 | Janney Montgomery Scott | Downgrade | Buy -> Neutral |
| 2024-10-30 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-10-30 | Benchmark | Reiterate | Buy -> Buy |
| 2024-10-22 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-26 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-05 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.644M 23.29% | 23.074M 201.86% | 31.821M 37.91% | 44.82M 40.85% | 150.97M 236.84% | 527.89M 249.67% | 1.667B 215.79% | 2.467B 47.99% | 1.35B -45.28% | |
| EBITDA YoY % growth | -188.814M -57.83% | -155.901M 17.43% | -141.442M 9.27% | -90.832M 35.78% | -68.718M 24.35% | 111.52M 262.29% | 839.32M 652.62% | 1.205B 43.57% | 469.2M -61.06% | |
| EBIT YoY % growth | -222.823M -75.37% | -200.862M 9.86% | -176.554M 12.10% | -167.867M 4.92% | -129.821M 22.66% | 147.69M 213.76% | 525.56M 255.85% | 844.43M 60.67% | 325.58M -61.44% | |
| Operating Margin | -2,915.01% | -870.51% | -554.83% | -374.54% | -85.99% | 27.98% | 31.53% | 34.23% | 24.12% | |
| EPS YoY % growth | -0.86 -43.33% | -0.73 15.12% | -0.56 23.29% | -0.62 -9.97% | -0.49 20.02% | 0.55 212.35% | 2.30 314.75% | 3.28 43.11% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 0.92% | -0.15 -13.21% | -0.16 -15.35% | -0.15 -9.29% | -0.01 94.85% | 0.01 106.58% | 0.02 109.79% | 0.04 126.00% | 0.01 180.00% | 0.01 -26.32% | 0.04 164.52% |
| Revenue Q2Q % growth | 7.116M 39.58% | 8.758M 17.27% | 16.135M 101.94% | 28.511M 153.09% | 40.234M 465.40% | 53.943M 515.93% | 69.824M 332.75% | 93.855M 229.19% | 76.51M 90.16% | 87.761M 62.69% | 118.34M 69.48% |
| EBITDA Q2Q % growth | -24.431M 28.38% | -25.681M 0.29% | -28.348M -39.66% | -25.437M -186.58% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -40.253M 5.42% | -41.179M 4.31% | -44.183M 5.94% | -41.939M 4.66% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
17 analysts have analysed ENVX and the average price target is 27.44 USD. This implies a price increase of 445.49% is expected in the next year compared to the current price of 5.03.
ENOVIX CORP (ENVX) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of ENOVIX CORP (ENVX) is -0.15 USD and the consensus revenue estimate is 7.12M USD.
The number of analysts covering ENOVIX CORP (ENVX) is 17.